StockData
ResMed Inc logo

ResMed Inc (RMD) stock

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3014% below fair value
$242.61+4.76 (+2.00%)

Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%

ResMed revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

ResMed's revenue for the twelve months ending Sep 30, 2026 was $5.73B, up 9.0% year over year. For fiscal 2026 it was $5.65B, up 9.9% from the year before. Over ten years it grew 11.9% a year on average. The highest annual figure on record is $5.65B in fiscal 2026.

Annual revenue

PeriodPeriod endValueChange
FY2026Jun 30, 2026$5.65B+9.9%
FY2025Jun 30, 2025$5.15B+9.8%
FY2024Jun 30, 2024$4.69B+10.9%
FY2023Jun 30, 2023$4.22B+18.0%
FY2022Jun 30, 2022$3.58B+11.9%
FY2021Jun 30, 2021$3.20B+8.1%
FY2020Jun 30, 2020$2.96B+13.4%
FY2019Jun 30, 2019$2.61B+11.4%
FY2018Jun 30, 2018$2.34B+13.2%
FY2017Jun 30, 2017$2.07B+12.4%
FY2016Jun 30, 2016$1.84B+9.5%
FY2015Jun 30, 2015$1.68B+8.0%
FY2014Jun 30, 2014$1.55B+2.7%
FY2013Jun 30, 2013$1.51B+10.7%
FY2012Jun 30, 2012$1.37B+10.1%
FY2011Jun 30, 2011$1.24B+13.8%
FY2010Jun 30, 2010$1.09B+18.6%
FY2009Jun 30, 2009$920.74M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$1.41B+5.9%
Q4 FY2026CQ2 2026Jun 30, 2026$1.46B+8.6%
Q3 FY2026CQ1 2026Mar 31, 2026$1.43B+10.8%
Q2 FY2026CQ4 2025Dec 31, 2025$1.42B+11.0%
Q1 FY2026CQ3 2025Sep 30, 2025$1.34B+9.1%
Q4 FY2025CQ2 2025Jun 30, 2025$1.35B+10.2%
Q3 FY2025CQ1 2025Mar 31, 2025$1.29B+7.9%
Q2 FY2025CQ4 2024Dec 31, 2024$1.28B+10.3%
Q1 FY2025CQ3 2024Sep 30, 2024$1.22B+11.1%
Q4 FY2024CQ2 2024Jun 30, 2024$1.22B+9.0%
Q3 FY2024CQ1 2024Mar 31, 2024$1.20B+7.2%
Q2 FY2024CQ4 2023Dec 31, 2023$1.16B+12.5%
Q1 FY2024CQ3 2023Sep 30, 2023$1.10B+16.0%
Q4 FY2023CQ2 2023Jun 30, 2023$1.12B+22.7%
Q3 FY2023CQ1 2023Mar 31, 2023$1.12B+29.2%
Q2 FY2023CQ4 2022Dec 31, 2022$1.03B+15.5%
Q1 FY2023CQ3 2022Sep 30, 2022$950.29M+5.1%
Q4 FY2022CQ2 2022Jun 30, 2022$914.74M+4.4%
Q3 FY2022CQ1 2022Mar 31, 2022$864.50M+12.5%
Q2 FY2022CQ4 2021Dec 31, 2021$894.87M+11.9%
Q1 FY2022CQ3 2021Sep 30, 2021$904.02M+20.2%
Q4 FY2021CQ2 2021Jun 30, 2021$876.10M+13.7%
Q3 FY2021CQ1 2021Mar 31, 2021$768.77M-0.1%
Q2 FY2021CQ4 2020Dec 31, 2020$800.01M+8.7%
Q1 FY2021CQ3 2020Sep 30, 2020$751.94M+10.4%
Q4 FY2020CQ2 2020Jun 30, 2020$770.34M+9.3%
Q3 FY2020CQ1 2020Mar 31, 2020$769.46M+16.2%
Q2 FY2020CQ4 2019Dec 31, 2019$736.16M+13.1%
Q1 FY2020CQ3 2019Sep 30, 2019$681.06M+15.8%
Q4 FY2019CQ2 2019Jun 30, 2019$704.96M+13.0%
Q3 FY2019CQ1 2019Mar 31, 2019$662.23M+11.9%
Q2 FY2019CQ4 2018Dec 31, 2018$651.10M+8.3%
Q1 FY2019CQ3 2018Sep 30, 2018$588.28M+12.3%
Q4 FY2018CQ2 2018Jun 30, 2018$623.63M+12.0%
Q3 FY2018CQ1 2018Mar 31, 2018$591.63M+15.1%
Q2 FY2018CQ4 2017Dec 31, 2017$601.27M+13.4%
Q1 FY2018CQ3 2017Sep 30, 2017$523.66M–
Q4 FY2017CQ2 2017Jun 30, 2017$556.69M–
Q3 FY2017CQ1 2017Mar 31, 2017$514.20M–
Q2 FY2017CQ4 2016Dec 31, 2016$530.40M–

More ResMed figures

See a number that looks wrong?